Access to Pre-Screened Patient Biobank

Because collaborative research is a critical focus, NASH Roundtable members have access to the NASH PASS database and biobank as a powerful platform to advance biomarker discovery and validation, endpoint determination, and the study of NAFLD/NASH as a multi-system disorder. The NASH PASS diagnostic and research platform utilizes Fibroscan imaging, laboratory testing, and proprietary algorithms to identify patients with NAFLD and those at high risk for NASH. As a result of the optimized screening, there is an abundance of data and biological specimens. These data allow for the opportunity to help expedite clinical research and help move the field forward.